Skip to content

A Prospective Study on the Therapeutic Effects of Transcutaneous Auricular Vagus Nerve Stimulation in Children with Global Developmental Delay

A Prospective Study on the Therapeutic Effects of Transcutaneous Auricular Vagus Nerve Stimulation in Children with Global Developmental Delay

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108375
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Global developmental delay

Interventions

Group 1 (taVNS Group):For taVNS treatment, the ear electrodes and the child’s ear are first cleaned with a warm, moist towel or conductive gel. The TVNS-100 transauricular vagus nerve stimulator is th
Group 2 (Sham Stimulation Group):For the sham taVNS treatment, the concha electrode is placed snugly against the skin of the ear concha, and the ear canal electrode is secured at the entrance of the e

Sponsors

The Third Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 5 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria (All of the following must be met): 1. Meets the diagnostic criteria for Global Developmental Delay (GDD) as defined in the *Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V)*; 2. Scores on at least two domains (including the adaptive domain) of the Gesell Developmental Scales–Chinese Revised Version must be >=25 and <75; 3. Age between 2 and 5 years; 4. No use of vasoactive medications (e.g., calcium channel blockers, nitrates, etc.) within the past month prior to enrollment to avoid interference of drug effects on cerebral hemodynamic signals; 5. Written informed consent provided by the legal guardian after thorough understanding of the study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (Any of the following applies): 1. Presence of skull defects or unhealed wounds on the head; 2. History of severe cerebrovascular disease; 3. Any other severe physical or mental disorders that may cause cerebral dysfunction; 4. Presence of epilepsy; 5. Severe fussing, excessive head movement, or inability to cooperate during the testing process.

Design outcomes

Primary

MeasureTime frame
Gesell Developmental Schedules;Multichannel near-infrared functional brain imaging;

Countries

China

Contacts

Public ContactDengna Zhu

The Third Affiliated Hospital of Zhengzhou University

zhudengna@126.com+86 138 3814 1626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026